Immune Checkpoint Inhibitor (ICI) Genes and Aging in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical and Genomic Study

Background: It is anticipated that there will be a large rise in the number of tumor diagnoses and mortality in those aged 65 and older over the course of upcoming decades. Immune checkpoint inhibitors, often known as ICIs, boost immune system activity by selectively targeting ICI genes. On the othe...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Danakh, Abdullah, Safi, Mohammed, Alradhi, Mohammed, Chen, Qiwei, Baldi, Salem, Zhu, Xinqing, Yang, Deyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688873/
https://www.ncbi.nlm.nih.gov/pubmed/36429070
http://dx.doi.org/10.3390/cells11223641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688873/
https://www.ncbi.nlm.nih.gov/pubmed/36429070
http://dx.doi.org/10.3390/cells11223641

Ejemplares similares